Literature DB >> 2435848

Subcellular localization of sulfated glucuronic acid-containing glycolipids reacting with anti-myelin-associated glycoprotein antibody.

T Kohriyama, S Kusunoki, T Ariga, J E Yoshino, G H DeVries, N Latov, R K Yu.   

Abstract

Peripheral nerve glycolipids, with which anti-myelin-associated glycoprotein (MAG) antibodies from patients with demyelinating neuropathy and plasma cell dyscrasia cross-react, proved to be novel glycosphingolipids containing a sulfated glucuronyl residue. Consequently, there has been much interest in the immunological role that these sulfated glucuronyl-glycosphingolipids (SGGLs) may play in the pathogenesis of this disorder. For the determination of the distribution of these glycolipids in various nervous tissues and, thereby, the elucidation of their pathogenicity, a quantitative immunostaining-TLC method for their detection has been devised. Using this method, we demonstrated that these glycolipids were distributed in greatly different amounts in the peripheral nerves from human, bovine, chicken, rat, and rabbit. Subcellular localization studies of bovine peripheral nerve also demonstrated that they were enriched in the axolemma-enriched fraction and present in glial-related membranes in lower concentrations. In addition, these glycolipids were present in bovine dura mater and transformed rat Schwann cells. These biochemical results suggest that not only myelin but also axons could be involved as targets of the anti-MAG antibody in macroglobulinemia neuropathy, and it may also be necessary to examine anti-SGGL activity in patients with axonal neuropathy associated with plasma cell dyscrasia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435848     DOI: 10.1111/j.1471-4159.1987.tb05694.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  A career perspective on the discipline of neurochemistry.

Authors:  George H DeVries
Journal:  Neurochem Res       Date:  2009-01       Impact factor: 3.996

2.  Sulfoglucuronosyl paragloboside promotes endothelial cell apoptosis in inflammation: elucidation of a novel glycosphingolipid-signaling pathway.

Authors:  Somsankar Dasgupta; Guanghu Wang; Robert K Yu
Journal:  J Neurochem       Date:  2011-10-11       Impact factor: 5.372

Review 3.  Gangliosides and glycosphingolipids of peripheral nervous system myelins--a minireview.

Authors:  K Ogawa-Goto; T Abe
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

4.  Regulation of sulfoglucuronyl glycolipid synthesis in the developing rat sciatic nerve.

Authors:  D K Chou; F B Jungalwala
Journal:  Neurochem Res       Date:  2001-11       Impact factor: 3.996

5.  Interleukin 1 beta up-regulates the expression of sulfoglucuronosyl paragloboside, a ligand for L-selectin, in brain microvascular endothelial cells.

Authors:  T Kanda; M Yamawaki; T Ariga; R K Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

Review 6.  Expression and biological functions of sulfoglucuronyl glycolipids (SGGLs) in the nervous system--a review.

Authors:  F B Jungalwala
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

7.  Sulfoglucuronosyl paragloboside is a ligand for T cell adhesion: regulation of sulfoglucuronosyl paragloboside expression via nuclear factor kappaB signaling.

Authors:  Somsankar Dasgupta; Jeane Silva; Guanghu Wang; Robert K Yu
Journal:  J Neurosci Res       Date:  2009-12       Impact factor: 4.164

8.  Autoantibodies against Forssman glycolipids in Graves' disease and Hashimoto's thyroiditis.

Authors:  T Ariga; T Yoshida; T Mimori; R K Yu
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

Review 9.  The role of sulfoglucuronosyl glycosphingolipids in the pathogenesis of monoclonal IgM paraproteinemia and peripheral neuropathy.

Authors:  Toshio Ariga
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

10.  Anti-Chol-1 antigen, GQ1bα, antibodies are associated with Alzheimer's disease.

Authors:  Toshio Ariga; Masaru Kubota; Makoto Nakane; Kenji Oguro; Robert K Yu; Susumu Ando
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.